Chargement en cours...
Inhibition of Angiopoietin-2 in LuCaP 23.1 Prostate Cancer Tumors Decreases Tumor Growth and Viability
BACKGROUND: Angiopoietin-2 is expressed in prostate cancer (PCa) bone, liver, and lymph node metastases, whereas, its competitor angiopoietin-1 has limited expression in these tissues. Therefore, we hypothesized that the inhibition of angiopoietin-2 activity in PCa metastasis (removed) will impede a...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3104406/ https://ncbi.nlm.nih.gov/pubmed/20583134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21216 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|